The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARIX.L Regulatory News (ARIX)

  • There is currently no data for ARIX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

8 Jul 2019 15:34

Arix Bioscience Plc - Holding(s) in Company

Arix Bioscience Plc - Holding(s) in Company

PR Newswire

London, July 8

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:Arix Bioscience Plc
1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify)iii: No trading in the stock - voting control interest over stock transferred to new managerX
3. Details of person subject to the notification obligationiv
NameWoodford Investment Management Ltd
City and country of registered office (if applicable)9400 Garsington Road, Oxford, OX4 2HN, United Kingdom
4. Full name of shareholder(s) (if different from 3.)v
Name
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reachedvi:05/07/2019
6. Date on which issuer notified (DD/MM/YYYY):08/07/2019
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8. A)% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)Total of both in % (8.A + 8.B)Total number of voting rights of issuervii
Resulting situation on the date on which threshold was crossed or reached19.78%19.78%135,551,850
Position of previous notification (if applicable)21.89%21.89%

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii
A: Voting rights attached to shares
Class/type of shares ISIN code (if possible)Number of voting rightsix% of voting rights
Direct (Art 9 of Directive 2004/109/EC) (DTR5.1)Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1)Direct (Art 9 of Directive 2004/109/EC) (DTR5.1)Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1)
GB00BD04507126,819,61719.78%
SUBTOTAL 8. A26,819,61719.78%

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrumentExpiration datexExercise/ Conversion PeriodxiNumber of voting rights that may be acquired if the instrument is exercised/converted.% of voting rights
SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrumentExpiration datexExercise/ Conversion Period xiPhysical or cash settlementxiiNumber of voting rights % of voting rights
SUBTOTAL 8.B.2

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an “X”)
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiiiX
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)
Namexv% of voting rights if it equals or is higher than the notifiable threshold% of voting rights through financial instruments if it equals or is higher than the notifiable thresholdTotal of both if it equals or is higher than the notifiable threshold
Woodford Investment Management Ltd19.780.0019.78
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional informationxvi

Place of completion9400 Garsington Road, Oxford, OX4 2HN, United Kingdom
Date of completion08/07/2019
Date   Source Headline
29th Jul 20215:30 pmEQSTransaction in own shares
28th Jul 20215:30 pmEQSTransaction in own shares
27th Jul 20215:05 pmEQSTransaction in own shares
27th Jul 20217:02 amEQSArtios raises $153m in Series C financing
26th Jul 20215:00 pmEQSTransaction in own shares
23rd Jul 20215:05 pmEQSTransaction in own shares
22nd Jul 20215:07 pmEQSTransaction in own shares
21st Jul 20215:19 pmEQSTransaction in own shares
21st Jul 20217:00 amEQSNotice of Results
20th Jul 20215:14 pmEQSTransaction in own shares
19th Jul 20215:19 pmEQSTransaction in own shares
16th Jul 20215:20 pmEQSTransaction in own shares
15th Jul 20215:19 pmEQSTransaction in own shares
14th Jul 20215:08 pmEQSTransaction in own shares
14th Jul 20219:00 amEQSImara announces pricing of public offering
14th Jul 20217:00 amEQSTransaction in own shares
12th Jul 20215:33 pmEQSTransaction in own shares
8th Jul 20215:15 pmEQSTransaction in own shares
7th Jul 20215:37 pmEQSTransaction in own shares
6th Jul 20215:26 pmEQSTransaction in own shares
6th Jul 20217:01 amEQSTeam changes
5th Jul 20214:59 pmEQSTransaction in own shares
1st Jul 20215:09 pmEQSTransaction in own shares
1st Jul 20217:01 amEQSTotal Voting Rights
30th Jun 20215:00 pmEQSTransaction in own shares
29th Jun 20214:54 pmEQSTransaction in own shares
28th Jun 20215:38 pmEQSTransaction in own shares
25th Jun 20214:57 pmEQSTransaction in own shares
24th Jun 20215:21 pmEQSTransaction in own shares
23rd Jun 20215:06 pmEQSTransaction in own shares
22nd Jun 20215:18 pmEQSTransaction in own shares
21st Jun 20215:06 pmEQSTransaction in own shares
18th Jun 20215:13 pmEQSTransaction in own shares
17th Jun 20215:12 pmEQSTransaction in own shares
16th Jun 20215:25 pmEQSTransaction in own shares
15th Jun 20215:40 pmEQSTransaction in own shares
14th Jun 20215:20 pmEQSTransaction in own shares
14th Jun 20212:55 pmEQSResults of Annual General Meeting
11th Jun 20215:01 pmEQSTransaction in own shares
11th Jun 20211:05 pmEQSClinical portfolio update
10th Jun 20215:26 pmEQSTransaction in own shares
9th Jun 20215:15 pmEQSTransaction in own shares
8th Jun 20215:14 pmEQSTransaction in own shares
7th Jun 20215:08 pmEQSTransaction in own shares
4th Jun 20215:13 pmEQSTransaction in own shares
4th Jun 20213:25 pmEQSHarpoon presents updated interim clinical data for HPN424 at the 2021 ASCO Annual Meeting
3rd Jun 20215:34 pmEQSTransaction in own shares
2nd Jun 20215:12 pmEQSTransaction in own shares
1st Jun 20215:35 pmEQSTransaction in own shares
1st Jun 20217:01 amEQSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.